Skip to content

Clinical trials

Completed Hepatitis B trials in Hong Kong

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatitis B Status: Completed Country / region: Hong Kong Clear all

35 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20031
20041
20051
20062
20071
20101
20112
20131
20151
20162
20172
20186
20205
20212
20224
20232

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed35

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline6
Vir Biotechnology, Inc.5
The University of Hong Kong4
Assembly Biosciences3
Bristol-Myers Squibb3
Arbutus Biopharma Corporation1
Arrowhead Pharmaceuticals1
Barinthus Biotherapeutics1
Bukwang Pharmaceutical1
Chinese University of Hong Kong1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis B35
Hepatitis B, Chronic19
Hepatitis9
Bronchiolitis Obliterans Syndrome2
Carcinoma, Hepatocellular2
Hepatitis, Chronic2
Chronic Disease1
HIV Infections1
HIV Seropositivity1
Hepatitis C1

Trials

Showing 1 to 25 of 35. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.